Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients

Fredholm, 2009, Breast cancer in young women: poor survival despite intensive treatment, PLoS One, 4, e7695, 10.1371/journal.pone.0007695 Anders, 2009, Breast cancer before age 40 years, Semin Oncol, 36, 237, 10.1053/j.seminoncol.2009.03.001 Meng, 2007, Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis, Zhonghua Zhong Liu Za Zhi, 29, 284 Gajdos, 2000, Stage 0 to stage III breast cancer in young women, J Am Coll Surg, 190, 523, 10.1016/S1072-7515(00)00257-X Jmor, 2002, Breast cancer in women aged 35 and under: prognosis and survival, J R Coll Surg Edinb, 47, 693 Anders, 2008, Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression, J Clin Oncol, 26, 3324, 10.1200/JCO.2007.14.2471 Morrison, 2012, Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer, Br J Cancer, 107, 382, 10.1038/bjc.2012.219 Carvalho, 2010, Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients, Clinics (Sao Paulo), 65, 1033, 10.1590/S1807-59322010001000019 Bacchi, 2010, Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: a pathological and immunohistochemical study, Breast, 19, 137, 10.1016/j.breast.2010.01.002 Winchester, 1996, The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age, Cancer, 78, 1838, 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y Albain, 1994, Breast cancer outcome and predictors of outcome: are there age differentials?, J Natl Cancer Inst Monogr, 16, 35 Kroman, 2000, Factors influencing the effect of age on prognosis in breast cancer: population based study, BMJ, 320, 474, 10.1136/bmj.320.7233.474 Wapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200/JCO.2005.04.3273 Azim, 2012, Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling, Clin Cancer Res, 18, 1341, 10.1158/1078-0432.CCR-11-2599 Edge, 2010, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, 17, 1471, 10.1245/s10434-010-0985-4 Sauter, 2009, Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations, J Clin Oncol, 27, 1323, 10.1200/JCO.2007.14.8197 Cheang, 2009, Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer, J Natl Cancer Inst, 101, 736, 10.1093/jnci/djp082 Goldhirsch, 2013, Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Ann Oncol, 24, 2206, 10.1093/annonc/mdt303 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 Sotiriou, 2003, Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci U S A, 100, 10393, 10.1073/pnas.1732912100 Creighton, 2012, The molecular profile of luminal B breast cancer, Biologics, 6, 289 Dowsett, 2011, Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group, J Natl Cancer Inst, 103, 1656, 10.1093/jnci/djr393 Polley, 2013, An international Ki67 reproducibility study, J Natl Cancer Inst, 105, 1897, 10.1093/jnci/djt306 Cui, 2005, Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy, J Clin Oncol, 23, 7721, 10.1200/JCO.2005.09.004 Rakha, 2007, Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype, J Clin Oncol, 25, 4772, 10.1200/JCO.2007.12.2747 Creighton, 2009, Molecular profiles of progesterone receptor loss in human breast tumors, Breast Cancer Res Treat, 114, 287, 10.1007/s10549-008-0017-2 Osborne, 2005, Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer, Clin Cancer Res, 11, 865s, 10.1158/1078-0432.865s.11.2 Arpino, 2005, Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance, J Natl Cancer Inst, 97, 1254, 10.1093/jnci/dji249